<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03004911</url>
  </required_header>
  <id_info>
    <org_study_id>274/14</org_study_id>
    <nct_id>NCT03004911</nct_id>
  </id_info>
  <brief_title>Development of a Mobile Application to Promote Self-care in Patients With Fibromyalgia</brief_title>
  <official_title>Development of a Mobile Application to Promote Self-care in Patients With Fibromyalgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the efficacy of a mobile application named ProFibro to
      promote self-care, and improve symptoms and health-related quality of life in Brazilian
      patients with fibromyalgia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2017</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health-related quality of life assessed with the Revised Fibromyalgia Impact Questionnaire</measure>
    <time_frame>Change from baseline at 6 weeks</time_frame>
    <description>The Revised Fibromyalgia Impact Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain assessed with the Widespread Pain Index</measure>
    <time_frame>Change from baseline at 6 weeks</time_frame>
    <description>Widespread Pain Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessed with the Visual Analogue Scale</measure>
    <time_frame>Change from baseline at 6 weeks</time_frame>
    <description>Visual Analogue Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of symptoms assessed with the Symptom Severity Scale</measure>
    <time_frame>Change from baseline at 6 weeks</time_frame>
    <description>Symptom Severity Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-care agency assessed with the Appraisal of Self-Care Agency Scale - Revised</measure>
    <time_frame>Change from baseline at 6 weeks</time_frame>
    <description>Appraisal of Self-Care Agency Scale - Revised</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to mobile application assessed by number of clicks on the app functions</measure>
    <time_frame>At 6 weeks</time_frame>
    <description>Number of clicks on the app functions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Mobile application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Paper booklet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ProFibro (Mobile application)</intervention_name>
    <description>ProFibro, a mobile Android application in Brazilian Portuguese to promote self-care in patients with fibromyalgia</description>
    <arm_group_label>Mobile application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Paper booklet</intervention_name>
    <description>A 64-page booklet with content similar to the mobile application</description>
    <arm_group_label>Paper booklet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of fibromyalgia, according to the 2010 American College of Rheumatology
             diagnostic criteria

          -  smartphone user

          -  complete primary education

        Exclusion Criteria:

          -  being in physical therapy treatment for fibromyalgia or having been treated in the
             last 3 months

          -  diagnosis of other chronic pain conditions (neuropathies, rheumatoid arthritis,
             osteoarthritis, spinal stenosis or cancer)

          -  severe mental disorders (schizophrenia, psychosis, bipolar affective disorder, severe
             depression)

          -  moderate or severe intellectual disability

          -  hearing or visual impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan LK Yuan, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rehabilitation Sciences PhD program of the School of Medicine of the University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amelia P Marques, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Physical Therapy, Speech Therapy and Occupational Therapy of the School of Medicine of the University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susan LK Yuan, MSc</last_name>
    <phone>+55 11 99582 9007</phone>
    <email>susanlkyuan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amelia P Marques, PhD</last_name>
    <phone>+55 11 3091 8423</phone>
    <email>pasqual@usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Physical Therapy, Speech Therapy and Occupational Therapy of the School of Medicine of the University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05360-160</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan LK Yuan, MSc</last_name>
      <phone>+55 11 3091 8423</phone>
      <email>susanlkyuan@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>https://profibro2018.wordpress.com/</url>
    <description>The website briefly explains the stages of the development of ProFibro, the main functions of the application and the test of its efficacy.</description>
  </link>
  <reference>
    <citation>Paiva ES, Heymann RE, Rezende MC, Helfenstein M Jr, Martinez JE, Provenza JR, Ranzolin A, de Assis MR, Pasqualin VD, Bennett RM. A Brazilian Portuguese version of the Revised Fibromyalgia Impact Questionnaire (FIQR): a validation study. Clin Rheumatol. 2013 Aug;32(8):1199-206. doi: 10.1007/s10067-013-2259-6. Epub 2013 Apr 21.</citation>
    <PMID>23604595</PMID>
  </reference>
  <reference>
    <citation>Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009 Jun;36(6):1304-11. doi: 10.3899/jrheum.081090. Epub 2009 Apr 15.</citation>
    <PMID>19369473</PMID>
  </reference>
  <reference>
    <citation>Altman DG, Bland JM. How to randomise. BMJ. 1999 Sep 11;319(7211):703-4. Review.</citation>
    <PMID>10480833</PMID>
  </reference>
  <reference>
    <citation>Henriksson C, Carlberg U, Kjällman M, Lundberg G, Henriksson KG. Evaluation of four outpatient educational programmes for patients with longstanding fibromyalgia. J Rehabil Med. 2004 Sep;36(5):211-9.</citation>
    <PMID>15626161</PMID>
  </reference>
  <reference>
    <citation>Nam S, Tin D, Bain L, Thorne JC, Ginsburg L. Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program. Clin Rheumatol. 2014 May;33(5):685-92. doi: 10.1007/s10067-013-2377-1. Epub 2013 Sep 1.</citation>
    <PMID>23995734</PMID>
  </reference>
  <reference>
    <citation>Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10. Erratum in: Arthritis Res Ther. 2009;11(5):415.</citation>
    <PMID>19664287</PMID>
  </reference>
  <reference>
    <citation>Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S154-62.</citation>
    <PMID>16273800</PMID>
  </reference>
  <reference>
    <citation>Marques AP, Assumpção A, Matsutani LA, Pereira CA, Lage L. Pain in fibromyalgia and discrimination power of the instruments: Visual Analog Scale, Dolorimetry and the McGill Pain Questionnaire. Acta Reumatol Port. 2008 Jul-Sep;33(3):345-51.</citation>
    <PMID>18846013</PMID>
  </reference>
  <reference>
    <citation>Sousa VD, Zauszniewski JA, Bergquist-Beringer S, Musil CM, Neese JB, Jaber AF. Reliability, validity and factor structure of the Appraisal of Self-Care Agency Scale-Revised (ASAS-R). J Eval Clin Pract. 2010 Dec;16(6):1031-40. doi: 10.1111/j.1365-2753.2009.01242.x.</citation>
    <PMID>20626539</PMID>
  </reference>
  <reference>
    <citation>Damásio BF, Koller SH. The Appraisal of Self-Care Agency Scale - Revised (ASAS-R): adaptation and construct validity in the Brazilian context. Cad Saude Publica. 2013 Oct;29(10):2071-82.</citation>
    <PMID>24127101</PMID>
  </reference>
  <reference>
    <citation>Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10. doi: 10.1002/acr.20140.</citation>
    <PMID>20461783</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2016</study_first_submitted>
  <study_first_submitted_qc>December 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2016</study_first_posted>
  <last_update_submitted>May 15, 2017</last_update_submitted>
  <last_update_submitted_qc>May 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fibromyalgia</keyword>
  <keyword>mobile application</keyword>
  <keyword>self-care</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

